The global lung cancer market is witnessing growth at a brisk speed, mainly due to the rising prevalence of the disease. The market appears to be well-developed with the availability of many novel treatments and therapeutics to deal with the condition. Also, there are various effective medical devices present in the market to be used in the treatment of lung cancer.
According to Market Research Future (MRFR), the global lung cancer market is poised to touch a valuation of USD 36,929.9 MN by 2023.
Request Sample Copy:
Global Lung Cancer Market – Segments
The report is segmented into four market dynamics to widen the scope of understanding,
By Type: Small-cell Lung Cancer (SCLC) and Non-small-cell Lung Cancer (NSCLC).
By Treatment : Chemotherapy, Surgery, Radiotherapy, Photodynamic Therapy (PDT), and Laser Therapy, among others.
By End-user: Hospital & Clinics, Cancer Research Centers, and Laboratories.
By Regions: Asia Pacific, North America, Europe, and the Rest-of-the-World.
Global Lung Cancer Market – Regional Analysis
North America leads the global lung cancer market with the increasing government support for research & development. The presence of the well-developed healthcare sector and a huge patient population, alongside, the high healthcare spending foster the growth of the market. The lung cancer market in the US, heading with the increasing healthcare spending accounts for the major growth contributor to the regional market.
The Asia Pacific lung cancer market is increasing owing to the significant advancements in the field of biotechnology and the increasing government support for the R&D activities required for the discoveries of breakthrough treatment and medicines for lung cancer. Additionally, rising healthcare expenditure and rapidly increasing awareness about the availability of the treatment are some of the factors driving the growth in the regional market.
Global Lung Cancer Market – Competitive Analysis
The lung cancer market appears widely expanded and highly competitive due to the presence of numerous players operating at the international level around the globe. Due to the expected extensions in products & services, the market is further expected to witness the fierce competition. Manufacturers operating in the lung cancer market strive to develop devices with adept technology and unrivalled design & features.
Major Players
Player leading the global lung cancer market include Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (US), Bristol-Myers Squibb Company (US), Merck & Co., Inc. (US), Sanofi (France), and Eli Lilly and Company (US), among others.
For More Details
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312